Mannkind (MNKD) Stock Price

$4.54 0%

Sign up
to add to portfolio

AI Score

Hold
  • Alternative

    7
  • Fundamental

    4
  • Technical

    3

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Mannkind, AI stock picks, stock alerts and much more.

Sign up

MNKD AI Stock Analysis

AI stock analysis for MNKD is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Mannkind (MNKD) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Mannkind (MNKD) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Mannkind (MNKD), currently trading at $4.54, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About MNKD

LSE
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States.

  • Symbol

    MNKD

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    1.4B

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX
$22.52
1.5%
5
INO Inovio Pharmaceuticals
INO
$1.74
1.2%
1
MRNA Moderna
MRNA
$24.72
1.9%
3
AVXL Anavex Life Sciences
AVXL
$8.95
1.2%
5
BBIO BridgeBio Pharma
BBIO
$33.87
0.1%
4

MNKD Alternative Data

Web Traffic

Mannkind receives an estimated 12628 monthly visitors to mannkindcorp.com.

  • Web Traffic

    12628

  • Change from Previous Month

    14.5%

  • 3 Month Change

    18.6%

  • YoY Change

    18.6%

News Mentions

Mannkind was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    100%

  • 1 Month Change

    100%

  • 3 Month Change

    0%

Reddit Mentions

Mannkind has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

Facebook Engagement

Mannkind has engaged 361 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    361

  • Daily Change

    12.8%

  • 1 Month Change

    381.3%

  • 3 Month Change

    759.5%

  • YoY Change

    759.5%

Youtube Subscribers

Mannkind has 271 subscribers on its main Youtube channel, down by -0.4% over the last month.

  • Youtube Subscribers

    271

  • Daily Change

    0%

  • 1 Month Change

    0.4%

  • 3 Month Change

    0%

  • YoY Change

    0%

LinkedIn Followers

14,393 are following Mannkind on LinkedIn, up by 2.5% over the last month.

  • LinkedIn Followers

    14393

  • Daily Change

    0%

  • 1 Month Change

    2.5%

  • 3 Month Change

    6.6%

Job Postings

Mannkind has an estimated 28 open job postings, which is down -22.2% over the last month.

  • Job Postings

    28

  • Daily Change

    0%

  • 1 Month Change

    22.2%

  • 3 Month Change

    16.7%

  • YoY Change

    16.7%

Twitter Followers

Mannkind has 2,780 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.8% over the last month.

  • Twitter Followers

    2780

  • Daily Change

    0%

  • 1 Month Change

    0.8%

  • 3 Month Change

    0.4%

  • YoY Change

    0.4%

Instagram Followers

Mannkind has 1,181 Instagram Followers on its main Instagram account, up by 4.6% over the last month.

  • Instagram Followers

    1181

  • Daily Change

    0.1%

  • 1 Month Change

    4.6%

  • 3 Month Change

    6.2%

  • YoY Change

    6.2%

LinkedIn Employees

According to LinkedIn, Mannkind has 572 employees.

  • LinkedIn Employees

    572

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    2.7%

  • YoY Change

    2.7%

Business Outlook

According to employee reviews, the business outlook among employees at Mannkind is 82 out of 100 (very bullish).

  • Business Outlook

    82

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

MNKD Financials

MNKD Key Metrics
  • Total Revenue

    $76.8M

  • Net Income

    $7.4M

  • Earnings per Share

    $0.027

  • Free cash flow

    $19.7M

  • EBITDA

    $18.6M

  • EBITDA Ratio

    0.242446

  • Total Assets

    $393.8M

MNKD 2-year Revenue & Income
MNKD 2-year Free Cash Flow

MNKD Technicals

MNKD SMA
MNKD RSI

FAQ

What's the current price of Mannkind (MNKD) Stock?
The price of an Mannkind (MNKD) share is $4.54.

What's the market cap of Mannkind?
The current market cap of Mannkind is 1.4B.

Should I buy or sell MNKD?
Mannkind shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Mannkind is better viewed as a hold or accumulate position while waiting for further developments.

Is Mannkind a good investment?
The current analysis of Mannkind's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Mannkind's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Mannkind (MNKD) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Mannkind stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Mannkind (MNKD) that investors often compare it to?
Mannkind (MNKD) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Mannkind's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Mannkind's stock price to be around $4.66 in 2026. Starting from the current price of $4.54, this represents a 2.6% change in price, indicating a neutral outlook for the stock.

How to buy Mannkind (MNKD) Stock?
Mannkind stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Mannkind shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.